Who we are
Professor Guy has over 30 years’ experience in medical research and global drug development. Founding the drug delivery company Ethical Holdings plc in 1985, he led the company to its NASDAQ listing in 1993. He also founded Phytopharm plc in 1989, of which he was Chairman until 1997. In 1998 Professor Guy founded GW Pharmaceuticals and he continues to serve as Chairman. Geoffrey has been the physician in charge of over 350 clinical studies, an author on over 70 scientific publications and has contributed to six books. Geoffrey holds a BSc. in pharmacology from the University of London, an MBBS at St. Bartholomew’s Hospital, an MRCS Eng. and LRCP London, an LMSSA, and a Diploma of Pharmaceutical Medicine from the Royal Colleges of Physicians. Geoffrey was appointed Visiting Professor at the University of Buckingham in July 2011 and in the same year he received the Deloitte Director of the Year Award in Pharmaceuticals and Healthcare. In 2016 Geoffrey was appointed Visiting Professor at the University of Westminster and awarded an honorary DSc from the University of Reading.
Kate trained as an SRN at St Bartholomew’s Hospital, London and worked at various hospitals in London, Buckinghamshire and Cambridge before having a family. Sharing Geoffrey’s passion for advancing medicine, she was instrumental in working with Geoffrey to set up the family trust. Kate helps to run several of Geoffrey’s business concerns and manages their family business based in Dorset, where they live.
Mr Richard Brass – Trustee
Richard Brass is the head of Wealth and Asset Management UK at Berenberg. He joined Berenberg from Schroders Private Banking, having started his career in corporate finance after qualifying as a chartered accountant at KPMG. He is the founder of Impact Ventures UK, a collaborative social impact fund focused on the UK. He is the chairman of the Arts Impact Fund Investment Committee, a board director of the London Philharmonic Orchestra and the Montpelier Foundation.
Mr Eric Dixon – Trustee
Eric was educated at East Ham Grammar School and then joined HM Royal Marines on a five year short service commission. On leaving the Marines, he trained as an Air Diver, specialising in underwater inspection and non-destructive testing. After working on various civil engineering projects, including the Thames Barrier, he then progressed to Saturation Diving and moved into the offshore oil industry. In 1989 he qualified as an Air and Mixed Gas Diving Supervisor controlling all types of diving operations, including diver lock-out submersibles. In 1999 he changed roles within the industry to become a Remotely Operated Vehicle Bridge Supervisor. This mainly involved work on BP’s deeper fields West of Shetland. During this time he became increasingly responsible for risk management and safe systems of work. After 38 years of working offshore, he retired in October 2017.
Jonathan read Human Sciences at St John’s College, Oxford and then trained as a Chartered Accountant with KPMG. After five years at KPMG he then worked for GW Pharmaceuticals for ten years, first as Finance Director and then Financial Controller. Jonathan left GW to pursue other interests and currently lives on a farm in Wiltshire with his wife and two sons.
Jimmy is a PhD biochemist who has worked at the forefront of scientific research into fatty acid metabolism and the use of both magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) to study the role of lipids in health and disease. In particular, he has gained world-wide recognition into his studies of the role of visceral adipose tissue (VAT) and diet and exercise and their relationship to a pre-diabetic condition called the metabolic syndrome. He is an author on over 300 scientific papers in this area and is frequently asked to appear on television to explain the underlying importance of VAT. He originally worked at Hammersmith Hospital, which later became part of Imperial College. He is now the director of the Research Centre for Optimal Health, based at University of Westminster, and also holds a chair at Imperial College.
Stan began his career at Harvard Medical School as a radiation oncologist research fellow. He is now based at the Central Laser Facility at Harwell, Oxfordshire, where he leads a team involved in the development of advanced microscopy, cellular DNA damage and repair, ultrafast biophysics, time resolved linear and non-linear fluorescence spectroscopy and microscopy, and application of lasers to biology and medicine. He is also an honorary Senior Research Fellow in the School of Biological Sciences, University of Bristol, and a Visiting Professor in the Faculty of Health and Life Sciences, Oxford Brookes University. He is an author on over 110 peer reviewed scientific publications. He is a member and a trustee of the Royal Microscopical Society, the Royal Society of Chemistry, Radiation Research (USA) and the Association of Radiation Research (UK).
Professor Wayne Frasch – Scientific Advisor
Wayne is the Biomedicine and Biotechnology faculty group leader in the School of Life Sciences, and is in the Biodesign Institute’s Center for Mechanisms of Evolution, at Arizona State University. His research focuses on bioenergetics, the molecular processes of biological energy conversion. Wayne pioneered single-molecule methods that provide a detailed understanding of ATP synthase molecular motors, and he created nanodevices for Attometrics LLC, the biotechnology company he founded. His PhD at the University of Kentucky was followed by postdoctoral studies at the University of Wisconsin before joining the faculty at the University of Michigan. He has over 80 peer-reviewed publications, and 11 patents. He served on Physical Biochemistry and BBM NIH study sections, NSF grant review panels, and the Journal of Biological Chemistry editorial board. In 2019, Wayne chaired the Bioenergetics Gordon Research Conference. He has been honored by several awards and fellowships including in 2012, the ASU Foundation Faculty Achievement Research Award, and the Arizona Governor’s Innovator of the Year Award, and in 2015, the Arizona Bioscience Researcher of the Year Award.
Dr Philip Kurian – Scientific Advisor
Philip is a theoretical physicist, natural philosopher, translational scientist, founding director of the Quantum Biology Laboratory at Howard University, and visiting research professor at Iowa Advanced Technology Laboratories. He is a Fulbright Scholar (Trieste) and recipient of awards from the Oak Ridge Leadership Computing Facility, Whole Genome Science Foundation and the NIH. He serves as the principal investigator for a federal study examining how water mediates electrodynamic correlations between biomolecules, and as co-PI for the conceptualization of an NSF challenge institute to develop novel platforms for quantum sensing and information processing in complex biological environments. His vision is to uncover how fundamentally quantum interactions (electron dispersion, photon excitation and phonon transduction) can produce biological manifestations at the mesoscopic and clinical scales, including in neurodegeneration, cancer, immunodiversity, oxidative metabolism and human consciousness. A board member for the AAAS Science for Seminaries program, Philip advises seminary professors on how to integrate frontier science topics into theological conversations, and he maintains a keen interest in African intellectual and cultural history.
Alistair is a PhD biochemist who began his post-doctoral scientific career studying how cells undergo programmed cell death (apoptosis) at Hammersmith Hospital, London. He continued his research in Edinburgh before moving into industry and worked in clinical safety and medical communications, whilst continuing his academic relationships. Alistair set up his own company in 2005, Broadmind Science, so he could act as an independent scientific advisor. Since that time Alistair has worked with both Geoffrey Guy and Jimmy Bell. From 2010-2015 he was supported by GW Pharmaceuticals in academic positions at Imperial College and the University of Reading. He is now largely a theoretician, specialising in mitochondrial function and the ageing process and what actually defines “health”: his approach is to study the origins of life and evolution, in particular, from the quantum and thermodynamic perspective. He is an author on more than 20 scientific papers and written chapters in two books. In 2019 he became a Visiting Professor at the University of Westminster, and now studies bioenergetics and quantum biology in association with the Research Centre for Optimal Health.
Nina has over twenty years’ experience in the charity and academic sectors. A health researcher at the Universities of Southampton and Birmingham, she moved to the charity sector as Executive Director at The Medicinal Cannabis Research Foundation. Nina went on to join the National Osteoporosis Society, working as Operations Director then Strategic Development Director. Previously Head of Health at the research agency Alterline, Nina joined The Guy Foundation in 2018. Nina read Human Sciences at University of Oxford and holds a Masters of Public Health (MPH) degree from University of Birmingham.